NYSE · Medical - Diagnostics & Research

TMO (TMO) Stock

$600.50 -2.69% NYSE: TMO Healthcare

Valuation

MetricValue
Price$600.50
Market Cap$223.16B
P/E Ratio34.03
P/B Ratio4.46
P/S Ratio5.08
EPS (TTM)$17.74
52-Week High$647.00
52-Week Low$435.27
Dividend Yield0.30%

Financials & Margins

MetricValue
ROE13.35%
ROA6.17%
ROCE8.35%
Gross Margin18.20%
Operating Margin18.20%
Net Margin15.06%
Debt/Equity0.81
Current Ratio1.89

Annual Financials (USD)

Metric20212022202320242025
Revenue$39.2B$44.9B$42.9B$42.9B$44.6B
Operating Profit$10.3B$8.5B$7.4B$7.7B$8.1B
Net Profit$7.7B$7.0B$6.0B$6.3B$6.7B
EPS$19.46$17.64$15.45$16.53$17.74
Op Margin26.3%19.0%17.4%17.9%18.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$95.1B$97.2B$98.7B$97.3B$110.3B
Total Liabilities$54.1B$53.0B$51.9B$47.6B$56.8B
Cash$4.5B$8.5B$8.1B$4.0B$9.9B
Borrowings$36.3B$36.1B$36.4B$32.8B$39.4B

Latest News

Thermo Fisher Scientific Announces Quarterly Dividend Business Wire · Jul 9, 2026 On the Eve of BIO 2026, Chinese Innovative Assets Trigger a New Wave of Global Collaborations PR Newswire · Jul 8, 2026 Cell Culture Media Market worth $12.9 billion by 2033: Biologics Manufacturing and Cell Therapy Expansion Accelerate Growth for Avantor, Thermo Fisher Scientific, and Lonza Group AG PR Newswire · Jul 8, 2026 Thermo Fisher (TMO) Wins FBI Approval For Rapid DNA Tool In Crime Investigations Simply Wall St. · Jul 7, 2026 Is ICLR Stock a Value Trap or Turnaround After an Earnings Reset? Zacks · Jul 7, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$9.5B$9.2B$8.4B$8.7B$7.8B
Investing Cash Flow$-24.5B$-4.4B$-6.6B$-7.2B$-5.6B
Financing Cash Flow$-1.9B$-3.0B$-2.9B$-3.8B$-2.9B
Net Cash Flow$-5.8B$4.0B$-440.0M$-4.1B$5.8B
Free Cash Flow$7.0B$6.9B$6.9B$7.3B$6.3B

Valuation & Return Ratios

MetricValue
PEG Ratio4.57
EV / EBITDA25.06
FCF Yield3.11%
Quick Ratio1.18
Interest Coverage5.59
Return 1Y27.51%
Return 3Y13.10%
Return 5Y7.63%

Ownership

Insiders Held0.15%
Institutions Held94.03%
Institutions Float Held94.17%
Institutional HolderSharesReport Date
Blackrock Inc.30,427,1922026-03-31
Vanguard Capital Management LLC24,280,8162026-03-31
State Street Corporation16,731,6682026-03-31
Morgan Stanley10,863,5282026-03-31
FMR, LLC10,776,4362026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
A $149.93 -2.36% 30.48 $42.35B 0.66%
ABT $108.97 -1.26% 36.69 $188.56B 2.21%
AMGN $438.12 +1.92% 27.15 $236.46B 2.29%
AZN $162.47 +0.21% 24.78 $251.97B 1.28%
DHR $206.93 -3.10% 38.12 $145.47B 0.74%

About TMO

TMO is led by CEO Marc N. Casper, employs 125,000 people, headquartered in Waltham, US, publicly traded since 1980.

TMO stock trades at $600.50 with a market capitalization of $223.16B. The stock is valued at a price-to-earnings (P/E) ratio of 34.03, price-to-book of 4.46, price-to-sales of 5.08. Over the past 52 weeks the stock has ranged between $435.27 and $647.00, and currently trades 7.2% below its 52-week high. It pays a dividend yielding 0.30%.

On profitability, TMO generates a return on equity (ROE) of 13.35%, above the typical market average, return on capital employed of 8.35%, an operating margin of 18.20%, a net profit margin of 15.06%.

In its most recent fiscal year, TMO reported annual revenue of $44.6B, net profit of $6.7B, revenue has compounded at 6.7% a year over the last five years, profit at 1.1% a year.

The balance sheet shows a debt-to-equity ratio of 0.81, a current ratio of 1.89, total assets of $110.3B, $9.9B in cash and equivalents.

TMO has a beta of 0.85.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1159.93 +0.28% JNJ Drug Manufacturers - General $271.19 +2.01% ABBV Drug Manufacturers - General $259.99 +1.39% MRK Drug Manufacturers - General $149.94 +1.48% UNH Medical - Healthcare Plans $396.30 +1.77% NVS Drug Manufacturers - General $161.25 +6.04% AZN Drug Manufacturers - General $162.47 +0.21% AMGN Drug Manufacturers - General $438.12 +1.92% NVO Biotechnology $45.12 -0.46% ABT Medical - Devices $108.97 -1.26% GILD Drug Manufacturers - General $149.92 +2.45% PFE Drug Manufacturers - General $28.55 +0.32%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides